
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. (AVIR)
WebsitePrice
Market cap
Next catalystEarly Q1 2027bemnifosbuvir and ruzasvir — C-BEYOND / C-FORWARD · Phase 3 dataSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
bemnifosbuvir (AT-527)
Viral RNA polymerase (RdRp) × HCV NS5B polymerase × SARS-CoV-2 nsp12 RdRp/NiRAN
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
History / paused
bemnifosbuvir (AT-527)
Viral RNA polymerase (RdRp) × HCV NS5B polymerase × SARS-CoV-2 nsp12 RdRp/NiRAN
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved